Fig. 2. Efficacy trial. Mean pain intensity (0–20-point Gracely scale) during the baseline and the final week of treatment with dextromethorphan (Dex), memantine (Mem), and active placebo in patients with diabetic neuropathy (top ; n = 19) and postherpetic neuralgia (bottom ; n = 17). Neither drug reduced pain significantly more than placebo.